Immutep Ltd (IMMP) Live Share Price, Invest From India

Immutep Ltd Stock Performance

as on October 24, 2025 at 1:29 am IST

Day's Low
Day's High
$1.96
Day's Price Range
$2.07
$2
2.00%
Downside
3.50%
Upside
52 Week's Low
52 Week's High
$1.32
52-Week Price Range
$2.71
$2
34.00%
Downside
35.50%
Upside

Immutep Ltd share price movements today

Previous Close: $2.00
Open: $1.96
Volume: 436.5K
Day's Low - High: $1.96 - $2.07
52 Week Low - High: $1.32 - $2.71

Immutep Ltd Historical Returns

1 Month Return: + 21.21 %
3 Month Return: + 19.05 %
1 Year Return: + 3.63 %
3 Year Return: + 5.26 %
5 Year Return: + 11.11 %

Immutep Ltd Stock Fundamentals & Key Indicators

Check Immutep Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$293.6M

EPS (TTM)

-0.2393

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-62.9M

Revenue (TTM)

5.0M

Profit Margin

0.00%

Return On Equity TTM

-36.88%

Immutep Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immutep Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Immutep Ltd	BUY	$293.6M	11.11%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$63.1B	252.62%	-505.15	-12.96%
Beone Medicines Ltd	NA	$35.3B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$109.3B	101.55%	30.36	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$61.3B	0.85%	14.6	31.37%

Stock Returns calculator for Immutep Ltd Stock including INR - Dollar returns

The Immutep Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Immutep Ltd investment value today

Current value as on today

₹1,08,280

Returns

₹8,280

(+8.28%)

Returns from Immutep Ltd Stock

₹3,627 (+3.63%)

Dollar Returns*

₹4,653 (+4.65%)

Analyst Recommendation on Immutep Ltd Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Immutep Ltd. Average target price of $9.5

Immutep Ltd Share Price Target

Get share price movements and forecasts by analysts on Immutep Ltd.

What analysts predicted

78.95%UPSIDE

Target Price

$9.5

Current Price

Analyzed by

9 Analysts

Target

$9.50

Immutep Ltd target price $9.5, a slight upside of 78.95% compared to current price of $2. According to 9 analysts rating.

Immutep Ltd Stock’s Investor Sentiment and Interest

Search interest for Immutep Ltd Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 24, 2025 to October 24, 2025

Change:13% versus previous 30 day period

Immutep Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2022	Dec 2022	Sep 2023	Dec 2023	Jun 2024	Sep 2024	Dec 2024	Jun 2025
Total Revenue	0	1	1	2	1	1	3	1
Gross Profit	0	0	0	1	-19	-19	-22	-34
Operating Income	-19	-23	-21	-43	-44	-44	-51	-74
EBITDA	-18	-20	-19	-22	-22	-22	-26	-36
Interest Expense	0	0	0	0	0	0	-	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-15	-20	-19	-21	-21	-21	-22	-39
Income Tax Expense	0	0	0	0	21	21	-	-
Net Income	-10	-13	-19	-21	-21	-21	-22	-39
Net Profit Margin	-9356.52%	-1223.54%	-1058.85%	-1005.72%	-1241.29%	-1241.29%	-710.92%	-2059.84%

Immutep Ltd Annual Profit & Loss

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	0	3	1	0	5	2	0	2	2	5
Gross Profit	-5	1	-5	-11	-10	-10	-1	0	-25	-56
Operating Income	-61	-9	-11	-20	-16	-31	-33	-77	-88	-126
EBITDA	-61	-8	-10	-18	-13	-17	-31	-39	-44	-62
Interest Expense	0	-	-	-	0	0	0	0	0	-
Depreciation	-	1	1	1	2	2	2	-	-	-
Income Before Tax	-63	-10	-12	-18	-13	-29	-32	-39	-42	-61
Income Tax Expense	-1	0	0	-2	0	0	0	0	0	-
Net Income	-45	-7	-9	-11	-9	-22	-22	-26	-28	-61
Net Profit Margin	-35426.72%	-221.89%	-484.55%	-11640.01%	-179.90%	-774.12%	-18906.51%	-1138.04%	-1111.87%	-1218.02%

Immutep Ltd Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-9	-19	-21	-	-21	-21	-22	-	-39
Operating Cash Flow	-8	-17	-17	-	-16	-7	-28	-	-33
Investing Cash Flow	0	0	0	-	-	-20	-30	-	24
Financing Cash Flow	76	38	0	0	95	95	0	0	0
Change in Cash	68	68	-6	-8	58	66	-46	-	-73

Immutep Ltd Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-9	-12	-18	-13	-29	-32	-39	-42	-61
Operating Cash Flow	-8	-7	-15	-10	-17	-30	-35	-34	-62
Investing Cash Flow	0	0	0	0	0	0	0	-21	-38
Financing Cash Flow	0	18	8	20	52	50	76	95	0
Change in Cash	-8	11	-6	9	34	19	43	38	-94

Global Institutional Holdings in Immutep Ltd

Funds	Holdings
BlackRock Inc	0.41%
Meridian Wealth Management, LLC	0.25%
Sender Co & Partners, Inc.	0.08%
Morgan Stanley - Brokerage Accounts	0.08%
UBS Group AG	0.04%

See all

Insights on Immutep Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, IMMP stock has moved up by 21.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 133.8% return, outperforming this stock by 128.5%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.7% return, outperforming this stock by 54.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 3.14M → 1.89M (in $), with an average decrease of 39.8% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 6 quarters, -19.27M → -39.05M (in $), with an average decrease of 18.0% per quarter

About Immutep Ltd

immutep is a globally active biotechnology company, listed on the australian stock exchange and on the nasdaq global market in the us. as a leader in personalized bio-therapeutic products for cancer, immutep is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders. immutep's main pipeline of products is based on the lag-3 immune control mechanism which plays a vital role in the regulation of the t cell immune response. the most clinically advanced product is a t cell immunostimulatory factor (apc activator), imp321, for cancer chemoimmunotherapy which has completed early phase ii trials. a number of additional lag-3 products including antibodies for immune response modulation in autoimmunity and cancer are being developed by large pharmaceutical partners.

Organisation	Immutep Ltd
Headquarters	Australia Square, Sydney, NSW, Australia, 2000
Industry	Health Technology
CEO	Mr. Marc Voigt
E-voting on shares	Click here to vote

Key Management of Immutep Ltd

Name	Title
Dr. Frederic Triebel M.D., Ph.D.	Chief Scientific Officer & Executive Director
Mr. Christian Mueller BBA, MSc.	Chief Development Officer
Mr. Stephan Winckels M.D., Ph.D.	Chief Medical Officer
Ms. Indira Naidu	Joint Company Secretary
Mr. Marc Voigt	CEO, MD, CFO, Chief Business Officer & Executive Director
Ms. Deanne Miller LLB	COO, General Counsel & Joint Company Secretary

FAQs

What is Immutep Ltd share price today?

Immutep Ltd share price today is $2 as on October 24, 2025 at 1:29 am IST at the close of the market. Immutep Ltd share today touched a day high of $2.07 and a low of $1.96.

What is the 52 week high and 52 week low for Immutep Ltd share?

Immutep Ltd share touched a 52 week high of $2.71 on May 5, 2025 and a 52 week low of $1.32 on April 7, 2025. Immutep Ltd stock price today i.e. October 24, 2025 at 1:29 am IST is closed at $2,which is 26.20% down from its 52 week high and 51.52% up from its 52 week low.

What is Immutep Ltd's market capitalisation today?

Immutep Ltd market capitalisation is $0.00T as on October 24, 2025 at 1:29 am IST.

How to invest in Immutep Ltd Stock (IMMP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Immutep Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immutep Ltd Shares that will get you 0.7500 shares as per Immutep Ltd share price of $2 per share as on October 24, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immutep Ltd Stock (IMMP) from India?

Indian investors can start investing in Immutep Ltd (IMMP) shares with as little as ₹87.835 or $1 (as of October 24, 2025 at 5:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.35 in Immutep Ltd stock (as per the Rupee-Dollar exchange rate as on October 24, 2025 at 5:38 am IST). Based on Immutep Ltd share’s latest price of $2 as on October 24, 2025 at 1:29 am IST, you will get 5.0000 shares of Immutep Ltd. Learn more about fractional shares .

What are the returns that Immutep Ltd has given to Indian investors in the last 5 years?

Immutep Ltd stock has given 11.11% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?